MRK Stock Down 1% in Pre-market, Merck Halts Its Covid-19 Vaccine Development

MRK Stock Down 1% in Pre-market, Merck Halts Its Covid-19 Vaccine Development

Continue reading at Coinspeaker

1,035
Like
Save